European Neuropsychopharmacology
Volume 19, Issue 9 , Pages 670-681 , September 2009

Modulation of the Ca2+ conductance of nicotinic acetylcholine receptors by Lypd6

  • Martin Darvas

      Affiliations

    • Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany
    • The first two authors contributed equally to this work.
    • ,
  • Marco Morsch

      Affiliations

    • Institute of Physiology, University of Bonn, Bonn, Germany
    • The first two authors contributed equally to this work.
    • ,
  • Ildiko Racz

      Affiliations

    • Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany
    • ,
  • Seifollah Ahmadi

      Affiliations

    • Institute of Physiology, University of Bonn, Bonn, Germany
    • ,
  • Dieter Swandulla

      Affiliations

    • Institute of Physiology, University of Bonn, Bonn, Germany
    • ,
  • Andreas Zimmer

      Affiliations

    • Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany
    • Corresponding Author InformationCorresponding author. Institute of Molecular Psychiatry, University of Bonn, Sigmund-Freud Str. 25, D-53127 Bonn, Germany. Tel.: +49 228 688 5300; fax: +49 228 688 5301.

Received 4 December 2008 ,Revised 10 March 2009 ,Accepted 31 March 2009.

References 

  1. Abreu-Villaca Y, Queiroz-Gomes FDO E, Dal Monte AP, Filgueiras CC, Manhaes AC. Individual differences in novelty-seeking behavior but not in anxiety response to a new environment can predict nicotine consumption in adolescent C57BL/6 mice. Behav. Brain Res. 2006;167:175–182
  2. Adermann K, Wattler F, Wattler S, Heine G, Meyer M, Forssmann WG, et al. Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily. Protein Sci. 1999;8:810–819
  3. Arredondo J, Chernyavsky AI, Jolkovsky DL, Webber RJ, Grando SA. SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium. J. Cell. Physiol. 2006;208:238–245
  4. Arredondo J, Chernyavsky AI, Webber RJ, Grando SA. Biological effects of SLURP-1 on human keratinocytes. J. Invest. Dermatol. 2005;125:1236–1241
  5. Behrendt N, Ploug M, Patthy L, Houen G, Blasi F, Dano K. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J. Biol. Chem. 1991;266:7842–7847
  6. Bilkei-Gorzo A, Racz I, Michel K, Darvas M, Maldonado R, Zimmer A. A common genetic predisposition to stress sensitivity and stress-induced nicotine craving. Biol. Psychiatry. 2008;63:164–171
  7. Bilkei-Gorzo A, Racz I, Michel K, Zimmer A, Klingmuller D, Zimmer A. Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds. Psychopharmacology (Berl). 2004;176:343–352
  8. Champtiaux N, Changeux JP. Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. Prog. Brain Res. 2004;145:235–251
  9. Chimienti F, Hogg RC, Plantard L, Lehmann C, Brakch N, Fischer J, et al. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum. Mol. Genet. 2003;12:3017–3024
  10. Curtis L, Buisson B, Bertrand S, Bertrand D. Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol. Mol. Pharmacol. 2002;61:127–135
  11. Dani JA. Overview of nicotinic receptors and their roles in the central nervous system. Biol. Psychiatry. 2001;49:166–174
  12. Decker MW, Anderson DJ, Brioni JD, Donnelly-Roberts DL, Kang CH, O'Neill AB, et al. Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors. Eur. J. Pharmacol. 1995;280:79–89
  13. Decker MW, Rueter LE, Bitner RS. Nicotinic acetylcholine receptor agonists: a potential new class of analgesics. Curr. Top. Med. Chem. 2004;4:369–384
  14. Descarries L, Gisiger V, Steriade M. Diffuse transmission by acetylcholine in the CNS. Prog. Neurobiol. 1997;53:603–625
  15. Dittgen T, Nimmerjahn A, Komai S, Licznerski P, Waters J, Margrie TW, et al. Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc. Natl. Acad. Sci. U. S. A. 2004;101:18206–18211
  16. Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Annu. Rev. Psychol. 1997;48:649–684
  17. Fleming TJ, O'Huigin C, Malek TR. Characterization of two novel Ly-6 genes. Protein sequence and potential structural similarity to alpha-bungarotoxin and other neurotoxins. J. Immunol. 1993;150:5379–5390
  18. Fucile S, Sucapane A, Eusebi F. Ca2+ permeability of nicotinic acetylcholine receptors from rat dorsal root ganglion neurones. J. Physiol. 2005;565:219–228
  19. Genzen JR, van Cleve W, McGehee DS. Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes. J. Neurophysiol. 2001;86:1773–1782
  20. Geyer MA, Mcilwain KL, Paylor R. Mouse genetic models for prepulse inhibition: an early review. Mol. Psychiatry. 2002;7:1039–1053
  21. Grailhe R, Waeber C, Dulawa SC, Hornung JP, Zhuang X, Brunner D, et al. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron. 1999;22:581–591
  22. Gumley TP, Mckenzie IF, Sandrin MS. Tissue expression, structure and function of the murine Ly-6 family of molecules. Immunol. Cell Biol. 1995;73:277–296
  23. Gustincich S, Batalov S, Beisel KW, Bono H, Carninci P, Fletcher CF, et al. Analysis of the mouse transcriptome for genes involved in the function of the nervous system. Genome Res. 2003;13:1395–1401
  24. Hanninen A, Jaakkola I, Salmi M, Simell O, Jalkanen S. Ly-6C regulates endothelial adhesion and homing of CD8(+) T cells by activating integrin-dependent adhesion pathways. Proc. Natl. Acad. Sci. U. S. A. 1997;94:6898–6903
  25. Hefft S, Hulo S, Bertrand D, Muller D. Synaptic transmission at nicotinic acetylcholine receptors in rat hippocampal organotypic cultures and slices. J. Physiol. 1999;515(Pt 3):769–776
  26. Hogarth PM, Mckenzie IF, Sutton VR, Curnow KM, Lee BK, Eicher EM. Mapping of the mouse Ly-6, Xp-14, and Gdc-1 loci to chromosome 15. Immunogenetics. 1987;25:21–27
  27. Hogg RC, Buisson B, Bertrand D. Allosteric modulation of ligand-gated ion channels. Biochem. Pharmacol. 2005;70:1267–1276
  28. Hurst RS, Hajos M, Raggenbass M, Wall TM, Higdon NR, Lawson JA, et al. A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J. Neurosci. 2005;25:4396–4405
  29. Ibanez-Tallon I, Miwa JM, Wang HL, Adams NC, Crabtree GW, Sine SM, et al. Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1. Neuron. 2002;33:893–903
  30. Ibanez-Tallon I, Wen H, Miwa JM, Xing J, Tekinay AB, Ono F, et al. Tethering naturally occurring peptide toxins for cell-autonomous modulation of ion channels and receptors in vivo. Neuron. 2004;43:305–311
  31. Krause RM, Buisson B, Bertrand S, Corringer PJ, Galzi JL, Changeux JP, et al. Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. 1998;53:283–294
  32. Lena C, Changeux JP, Mulle C. Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 1993;13:2680–2688
  33. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408
  34. Maelicke A, Samochocki M, Jostock R, Fehrenbacher A, Ludwig J, Albuquerque EX, et al. Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease. Biol. Psychiatry. 2001;49:279–288
  35. Mallya M, Campbell RD, Aguado B. Characterization of the five novel Ly-6 superfamily members encoded in the MHC, and detection of cells expressing their potential ligands. Protein Sci. 2006;15:2244–2256
  36. Marubio LM, Del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Lena C, Le Novere N, de Kerchove D'Exaerde A, et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 1999;398:805–810
  37. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature. 2005;436:103–107
  38. McGehee DS, Heath MJ, Gelber S, Devay P, Role LW. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 1995;269:1692–1696
  39. Miwa JM, Ibanez-Tallon I, Crabtree GW, Sanchez R, Sali A, Role LW, et al. lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS. Neuron. 1999;23:105–114
  40. Miwa JM, Stevens TR, King SL, Caldarone BJ, Ibanez-Tallon I, Xiao C, et al. The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo. Neuron. 2006;51:587–600
  41. Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S, et al Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002;420:563–573
  42. Picciotto MR, Caldarone BJ, King SL, Zachariou V. Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology. 2000;22:451–465
  43. Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, Le Novere N, et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature. 1995;374:65–67
  44. Ploug M, Ellis V. Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins. FEBS Lett. 1994;349:163–168
  45. Racz I, Schutz B, Abo-Salem OM, Zimmer A. Visceral, inflammatory and neuropathic pain in glycine receptor alpha 3-deficient mice. Neuroreport. 2005;16:2025–2028
  46. Roerig B, Nelson DA, Katz LC. Fast synaptic signaling by nicotinic acetylcholine and serotonin 5-HT3 receptors in developing visual cortex. J. Neurosci. 1997;17:8353–8362
  47. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 2003;33:401–406
  48. Stevens KE, Wear KD. Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models. Pharmacol. Biochem. Behav. 1997;57:869–874
  49. Suto N, Austin JD, Vezina P. Locomotor response to novelty predicts a rat's propensity to self-administer nicotine. Psychopharmacology (Berl). 2001;158:175–180
  50. Tassonyi E, Charpantier E, Muller D, Dumont L, Bertrand D. The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res. Bull. 2002;57:133–150
  51. Vincler MA, Eisenach JC. Knock down of the alpha 5 nicotinic acetylcholine receptor in spinal nerve-ligated rats alleviates mechanical allodynia. Pharmacol. Biochem. Behav. 2005;80:135–143
  52. Vizi ES. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Pharmacol. Rev. 2000;52:63–89
  53. Zwart R, De Filippi G, Broad LM, Mcphie GI, Pearson KH, Baldwinson T, et al. 5-Hydroxyindole potentiates human alpha 7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices. Neuropharmacology. 2002;43:374–384

PII: S0924-977X(09)00094-7

doi: 10.1016/j.euroneuro.2009.03.007

European Neuropsychopharmacology
Volume 19, Issue 9 , Pages 670-681 , September 2009

Article Tools

* Image Usage & Resolution